Literature DB >> 12357219

Streptococcus pyogenes and phagocytic killing.

Ulrich von Pawel-Rammingen, Björn P Johansson, Hans Tapper, Lars Björck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12357219     DOI： 10.1038/nm1002-1044

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  9 in total

Review 1.  Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes.

Authors:  Mattias Collin; Arne Olsén
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

2.  Immunoglobulin cleavage by the streptococcal cysteine protease IdeS can be detected using protein G capture and mass spectrometry.

Authors:  Jennifer L Hess; Eric A Porsch; Cecelia A Shertz; Michael D P Boyle
Journal:  J Microbiol Methods       Date:  2007-05-05       Impact factor: 2.363

3.  IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection.

Authors:  Per Akesson; Linnea Moritz; Mikael Truedsson; Bertil Christensson; Ulrich von Pawel-Rammingen
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG.

Authors:  Katja Wenig; Lorenz Chatwell; Ulrich von Pawel-Rammingen; Lars Björck; Robert Huber; Peter Sondermann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

5.  The intrinsic immunoglobulin g endopeptidase activity of streptococcal Mac-2 proteins implies a unique role for the enzymatically impaired Mac-2 protein of M28 serotype strains.

Authors:  Jenny Johansson Söderberg; Patrik Engström; Ulrich von Pawel-Rammingen
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

6.  Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic Opportunity.

Authors:  Lena Winstedt; Sofia Järnum; Emma Andersson Nordahl; Andreas Olsson; Anna Runström; Robert Bockermann; Christofer Karlsson; Johan Malmström; Gabriella Samuelsson Palmgren; Ulf Malmqvist; Lars Björck; Christian Kjellman
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

7.  Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.

Authors:  Tomas Lorant; Mats Bengtsson; Torsten Eich; Britt-Marie Eriksson; Lena Winstedt; Sofia Järnum; Yvonne Stenberg; Anna-Karin Robertson; Kristina Mosén; Lars Björck; Lars Bäckman; Erik Larsson; Kathryn Wood; Gunnar Tufveson; Christian Kjellman
Journal:  Am J Transplant       Date:  2018-04-17       Impact factor: 8.086

Review 8.  The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections.

Authors:  Patience Shumba; Srikanth Mairpady Shambat; Nikolai Siemens
Journal:  Toxins (Basel)       Date:  2019-06-11       Impact factor: 4.546

9.  Streptococcus pyogenes Infection and the Human Proteome with a Special Focus on the Immunoglobulin G-cleaving Enzyme IdeS.

Authors:  Christofer A Q Karlsson; Sofia Järnum; Lena Winstedt; Christian Kjellman; Lars Björck; Adam Linder; Johan A Malmström
Journal:  Mol Cell Proteomics       Date:  2018-03-06       Impact factor: 5.911
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.